文献速递骨软组织肉瘤与黑色素瘤

荷兰儿童与青少年及年轻成人尤文肉瘤的生存差异自20世纪90年代以来未改变尽管生存率有所提高:一项基于人群的研究

The survival disparity between children and adolescents and young adults (AYAs) with Ewing sarcoma in the Netherlands did not change since the 1990s despite improved survival: A population-based study.
PubMed 文献 · Eur J Cancer · 2024-07-06

该荷兰基于人群研究纳入1990-2018年诊断的0-17岁儿童(N=463)和18-39岁青少年及年轻成人(AYAs,N=379)尤文肉瘤患者,随访至2023年2月。儿童5年相对生存率显著高于AYAs(65% vs 44%),调整后AYAs超额死亡风险仍增高(excess HR:1.7,95%CI:1.3-2.1),生存差异在不同组织来源、肿瘤部位和疾病分期中均存在。

要点

  • 儿童尤文肉瘤5年相对生存率显著高于AYAs(65% vs 44%)。
  • 2010-2018年儿童生存率达70%,AYAs为53%。
  • 调整后AYAs超额死亡风险增高(excess HR:1.7,95%CI:1.3-2.1)。

核心结论

  • 尽管自20世纪90年代以来生存率有所改善,荷兰AYAs尤文肉瘤患者预后仍显著差于儿童,且该差异与组织来源、肿瘤部位和疾病分期无关。

研究设计与样本

  • 荷兰基于人群研究,从荷兰癌症登记处收集1990-2018年诊断的所有儿童(0-17岁,N=463)和AYAs(18-39岁,N=379)尤文肉瘤患者数据,随访至2023年2月。
  • 采用队列法计算5年相对生存率,通过泊松回归进行多变量分析。

主要发现

  • 儿童尤文肉瘤5年相对生存率显著高于AYAs(65% vs 44%)。
  • 生存率呈上升趋势,2010-2018年儿童达70%,AYAs达53%。
  • 尤文骨肉瘤和骨外尤文肉瘤结果相似。
  • 大多数肿瘤部位及无论疾病分期,AYAs预后均差于儿童;局限期生存率60% vs 78%,转移期20% vs 33%。
  • 调整随访时间、诊断时期、性别、疾病分期和肿瘤部位后,AYAs较儿童超额死亡风险增高(excess HR:1.7,95%CI:1.3-2.1)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Adolescents and young adults (AYAs) with Ewing sarcoma have a worse prognosis than children. Population-based survival evaluations stratifying findings by important clinical factors are, however, limited. This Dutch population study comprehensively compared survival of children and AYAs with Ewing sarcoma over three decades considering diagnostic period, tissue of origin, tumor site, and disease stage. METHODS: Data on all children (0-17 years, N = 463) and AYAs (18-39 years, N = 379) diagnosed with Ewing sarcoma in the Netherlands between 1990-2018 were collected from the Netherlands Cancer Registry with follow-up until February 2023. Five-year relative survival was calculated using the cohort method. Multivariable analyses were conducted through Poisson regression. RESULTS: Children with Ewing sarcoma had a significantly higher 5-year relative survival than AYAs (65 % vs. 44 %). An increasing trend in survival was noted reaching 70 % in children and 53 % in AYAs in 2010-2018. Results were similar for Ewing bone sarcoma and extraosseous Ewing sarcoma. AYAs had a poorer prognosis than children for most tumor sites and regardless of disease stage. Survival probabilities were 60 % vs. 78 % for localized disease and 20 % vs. 33 % for metastatic disease. Multivariable-regression analysis, adjusted for follow-up time, diagnostic period, sex, disease stage, and tumor site, confirmed increased excess mortality among AYAs compared with children (excess HR: 1.7, 95 % CI: 1.3-2.1). CONCLUSIONS: Despite survival improvements since the 1990s, AYAs with Ewing sarcoma in the Netherlands continue to fare considerably worse than children. This survival disparity was present irrespective of tissue of origin, tumor site, and disease stage.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Schulpen M, Haveman LM, van der Heijden L, et al. The survival disparity between children and adolescents and young adults (AYAs) with Ewing sarcoma in the Netherlands did not change since the 1990s despite improved survival: A population-based study. Eur J Cancer. 2024. PMID: 39018631. doi:10.1016/j.ejca.2024.114209

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。